According to the expression of hormone receptors, we call a type of breast cancer that lacks the expression of estrogen receptor (ER), progesterone receptor (PR) and human epithelial growth factor receptor 2 (Her-2) as triple negative breast cancer (TNBC) (2, 3). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.